CY1121865T1 - Οφθαλμολογικες συνθεσεις και η χρηση τους - Google Patents
Οφθαλμολογικες συνθεσεις και η χρηση τουςInfo
- Publication number
- CY1121865T1 CY1121865T1 CY20191100828T CY191100828T CY1121865T1 CY 1121865 T1 CY1121865 T1 CY 1121865T1 CY 20191100828 T CY20191100828 T CY 20191100828T CY 191100828 T CY191100828 T CY 191100828T CY 1121865 T1 CY1121865 T1 CY 1121865T1
- Authority
- CY
- Cyprus
- Prior art keywords
- ophthalmological compositions
- eye prior
- agent
- instilled
- infused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Η ευρεσιτεχνία αφορά σε μία φαρμακευτική σύνθεση που χαρακτηρίζεται από το ότι περιέχει ένα συνδυασμό από ένα παρασυμπαθολυτικό παράγοντα, ένα συμπαθομιμητικό παράγοντα και ένα τοπικό αναισθητικό. Μία τέτοια σύνθεση μπορεί να εκχυθεί μέσα στον πρόσθιο θάλαμο του οφθαλμού πριν από μία επέμβαση καταρράκτη ή να ενσταλαχτεί πάνω στον οφθαλμό πριν από μία θεραπεία με λέιζερ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0502357A FR2882930B1 (fr) | 2005-03-09 | 2005-03-09 | Nouvelles compositions ophtalmologiques et leur mode d'utilisation |
PCT/FR2006/000528 WO2006095095A1 (fr) | 2005-03-09 | 2006-03-09 | Compositions ophtalmologiques et leur mode d’utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1121865T1 true CY1121865T1 (el) | 2020-05-29 |
Family
ID=35058756
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20191100828T CY1121865T1 (el) | 2005-03-09 | 2019-08-05 | Οφθαλμολογικες συνθεσεις και η χρηση τους |
CY2019042C CY2019042I1 (el) | 2005-03-09 | 2019-11-05 | Οφθαλμολογικες συνθεσεις και η χρηση τους |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY2019042C CY2019042I1 (el) | 2005-03-09 | 2019-11-05 | Οφθαλμολογικες συνθεσεις και η χρηση τους |
Country Status (26)
Country | Link |
---|---|
US (2) | US20080194649A1 (el) |
EP (1) | EP1858481B1 (el) |
JP (1) | JP2008532985A (el) |
KR (1) | KR20070111501A (el) |
CN (1) | CN101151018A (el) |
CA (1) | CA2598503C (el) |
CY (2) | CY1121865T1 (el) |
DK (1) | DK1858481T3 (el) |
ES (1) | ES2728071T3 (el) |
FR (1) | FR2882930B1 (el) |
HR (1) | HRP20191044T1 (el) |
HU (1) | HUE043668T2 (el) |
IL (1) | IL185197A0 (el) |
LT (2) | LT1858481T (el) |
LU (1) | LUC00136I2 (el) |
MA (1) | MA29269B1 (el) |
MX (1) | MX2007010295A (el) |
NL (1) | NL301017I2 (el) |
NO (2) | NO339793B1 (el) |
PL (1) | PL1858481T3 (el) |
PT (1) | PT1858481T (el) |
RU (1) | RU2392925C2 (el) |
SI (1) | SI1858481T1 (el) |
TN (1) | TNSN07343A1 (el) |
TR (1) | TR201908487T4 (el) |
WO (1) | WO2006095095A1 (el) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8602959B1 (en) * | 2010-05-21 | 2013-12-10 | Robert Park | Methods and devices for delivery of radiation to the posterior portion of the eye |
EP2675455A4 (en) * | 2011-02-18 | 2014-07-16 | M S Appasamy Associates | OPHTHALMIC COMPOSITION FOR DILATING PUPILS |
ITPA20110004A1 (it) * | 2011-02-23 | 2012-08-24 | Francesco Paolo Montalto | Iniezione intracamerulare per anestesia e dilatazione pupillare (midriasi). |
CN103159672A (zh) * | 2012-07-16 | 2013-06-19 | 湖南尔文生物科技有限公司 | 一种托品酰胺的制备方法 |
AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
RU2525512C1 (ru) * | 2013-03-28 | 2014-08-20 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ медикаментозного расширения ригидного зрачка перед проведением факоэмульсификации |
MX2016004257A (es) * | 2013-10-03 | 2016-08-17 | Imprimis Pharmaceuticals Inc | Composiciones oftalmicas basadas en epinefrina para la administracion intraocular y metodos para su frabricacion. |
CN105213418B (zh) * | 2015-11-11 | 2019-01-22 | 中国人民解放军第四军医大学 | 一种眼科术前用复方滴眼液及其制备方法 |
JP2019524896A (ja) | 2016-08-25 | 2019-09-05 | ハーロウ・ヘルス・インコーポレイテッドHarrow Health, Inc. | 眼内投与のためのエピネフリンベースの眼科組成物及びその製造方法 |
RU2649534C1 (ru) * | 2017-05-10 | 2018-04-03 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) | Способ анестезии при факоэмульсификации катаракты |
RU2662423C1 (ru) * | 2017-07-26 | 2018-07-25 | Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ проведения обезболивания при выполнении витреоретинальных операций |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3026323A (en) * | 1960-03-22 | 1962-03-20 | Rubin J Schacter | Salts of tribasic acids |
JPH0780760B2 (ja) * | 1986-07-28 | 1995-08-30 | ライオン株式会社 | 安定化されたフエニレフリン系液剤 |
JP3066561B2 (ja) * | 1993-10-07 | 2000-07-17 | 武田薬品工業株式会社 | 近視予防・治療剤 |
US5686414A (en) * | 1995-11-14 | 1997-11-11 | Xoma Corporation | Methods of treating conditions associated with corneal transplantation |
US5779661A (en) * | 1995-12-11 | 1998-07-14 | Physion, S.R.L. | Method of treating dysfunctional bladder syndromes by electromotive drug administration |
US6319240B1 (en) * | 1999-05-25 | 2001-11-20 | Iomed, Inc. | Methods and apparatus for ocular iontophoresis |
CA2391448A1 (en) * | 1999-11-12 | 2001-05-17 | Leo Rubin | Use of vasoactive intestinal peptides and kits therefor |
US6218428B1 (en) * | 2000-04-28 | 2001-04-17 | Emil Chynn | Ophthalmic composition |
JP4150846B2 (ja) * | 2001-03-28 | 2008-09-17 | 参天製薬株式会社 | ステロイドを有効成分とする網脈絡膜疾患治療剤 |
US20040013729A1 (en) * | 2002-07-18 | 2004-01-22 | Buono Lawrence M. | Single-drop multiple-agent composition for topical delivery to the eye |
AU2003261304A1 (en) * | 2002-07-30 | 2004-02-16 | Omeros Corporation | Ophthalmologic irrigation solutions and method |
-
2005
- 2005-03-09 FR FR0502357A patent/FR2882930B1/fr active Active
-
2006
- 2006-03-09 MX MX2007010295A patent/MX2007010295A/es active IP Right Grant
- 2006-03-09 LT LTEP06726059.6T patent/LT1858481T/lt unknown
- 2006-03-09 SI SI200632328T patent/SI1858481T1/sl unknown
- 2006-03-09 CN CNA2006800074102A patent/CN101151018A/zh active Pending
- 2006-03-09 DK DK06726059.6T patent/DK1858481T3/da active
- 2006-03-09 EP EP06726059.6A patent/EP1858481B1/fr active Active
- 2006-03-09 RU RU2007137115/15A patent/RU2392925C2/ru active
- 2006-03-09 HU HUE06726059A patent/HUE043668T2/hu unknown
- 2006-03-09 CA CA2598503A patent/CA2598503C/fr active Active
- 2006-03-09 KR KR1020077019402A patent/KR20070111501A/ko not_active Application Discontinuation
- 2006-03-09 JP JP2008500234A patent/JP2008532985A/ja active Pending
- 2006-03-09 ES ES06726059T patent/ES2728071T3/es active Active
- 2006-03-09 WO PCT/FR2006/000528 patent/WO2006095095A1/fr active Application Filing
- 2006-03-09 PT PT06726059T patent/PT1858481T/pt unknown
- 2006-03-09 PL PL06726059T patent/PL1858481T3/pl unknown
- 2006-03-09 TR TR2019/08487T patent/TR201908487T4/tr unknown
- 2006-03-09 US US11/908,161 patent/US20080194649A1/en not_active Abandoned
-
2007
- 2007-08-12 IL IL185197A patent/IL185197A0/en unknown
- 2007-08-27 MA MA30165A patent/MA29269B1/fr unknown
- 2007-09-07 TN TNP2007000343A patent/TNSN07343A1/fr unknown
- 2007-09-24 NO NO20074850A patent/NO339793B1/no active Protection Beyond IP Right Term
-
2012
- 2012-05-04 US US13/464,524 patent/US9289399B2/en active Active
-
2017
- 2017-03-24 NO NO2017008C patent/NO2017008I2/no unknown
-
2019
- 2019-06-11 HR HRP20191044TT patent/HRP20191044T1/hr unknown
- 2019-08-05 CY CY20191100828T patent/CY1121865T1/el unknown
- 2019-10-30 NL NL301017C patent/NL301017I2/nl unknown
- 2019-11-04 LU LU00136C patent/LUC00136I2/fr unknown
- 2019-11-05 CY CY2019042C patent/CY2019042I1/el unknown
- 2019-11-07 LT LTPA2019017 patent/LTPA2019017I1/lt unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121865T1 (el) | Οφθαλμολογικες συνθεσεις και η χρηση τους | |
CY1125077T1 (el) | Αγωγη της ανεπαρκειας και ελλειψης βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3 | |
CY1125202T1 (el) | Συνδυασμοι που περιλαμβανουν παραγωγα 5-φαινοξυ-3η-πυριμιδιν-4-ονης και η χρηση αυτων για την προφυλαξη ή αγωγη λοιμωξης απο hiv | |
CY1120879T1 (el) | Πολλαπλου συστατικου βιοδραστικος ενδοκολπικος δακτυλιος | |
CY1115891T1 (el) | Φαρμακευτικες συνθεσεις για την αντιμετωπιση των διαταραχων του εσω ωτος | |
LTPA2017009I1 (lt) | Brutono tirozinkinazės inhibitoriai | |
CY1113963T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος | |
CY1118731T1 (el) | Φαρμακευτικες συνθεσεις αλβιγλουτιδης | |
CY1111613T1 (el) | Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv | |
DE602006009834D1 (de) | Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung | |
ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
CY1117995T1 (el) | Δευτεριωμενα παραγωγα κατεχολαμινης και φαρμακα που περιεχουν τις εν λογω ενωσεις | |
EA200802390A1 (ru) | Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их | |
CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
EA201000897A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
MX351152B (es) | Compstatina y analogos de la misma para tratar trastornos oculares. | |
TR201907874T4 (tr) | Düşük sülfat fukanlar kullanarak fibröz yapışmaları ya da inflamatuar hastalıkları inhibe etmeye yönelik farmasötik kompozisyonlar ve yöntemler. | |
MY172185A (en) | Artificial tears and therapeutic uses | |
AR068185A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
ECSP067062A (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
ECSP088208A (es) | Nuevos inhibidores macrocíclicos de la replicación del virus de hepatitis c | |
CL2011002548A1 (es) | Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica. | |
MX2008008556A (es) | Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias. | |
MX2021006884A (es) | Compuestos y su uso para el tratamiento de la deficiencia de alfa1-antitripsina. | |
CY1115384T1 (el) | Αντι-φλεγμονωδης συνθεση |